Phase II study of elliptinium acetate salvage treatment of advanced breast cancer-Reference-Cited by-同舟云学术

Phase II study of elliptinium acetate salvage treatment of advanced breast cancer

Published:1993-01 Issue:6 Volume:29 Page:856-859
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Rouëssé J.,Spielmann M.,Turpin F.,Le Chevalier T.,Azab M.,Mondésir J.M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Alkaloids of Ochrosia maculata Jacq. (Ochrosia borbonica Gmel.): isolation of the alkaloids and study of the antitumour properties of 9-methoxy ellipticine;Svoboda;J Pharm Sci,1968

2. A new antitumoral agent: 9-hydroxy ellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs;Le Pecq,1974

3. Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl 9-hydroxy ellipticinium;Zwelling;Biochem Pharmacol,1982

4. Autoxidation of the antitumor drug 9-hydroxy ellipticine and its derivatives;Auclair;J Med Chem,1983

5. Ellipticine derivatives interacting with model membranes. Influence of quaternarization of nitrogen-2;Lempereur;Biochem Pharmacol,1984

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of carbazole derivatives as potent antibacterial agents targeting membrane function via FabH Inhibition;Journal of Molecular Structure;2024-06

2. Gold-catalyzed benzannulations of 2-alkenylindoles with alkynes: a protecting-group-free regioselective approach to carbazoles;Chemical Communications;2024

3. Rh(I)-Catalyzed Cascade Carbonylative Cyclization of Propargyl α-Diazoindolacetates for Construction of Carbazoles;Organic Letters;2023-11-07

4. Considering the Conception of Nanotechnology Integrated on Herbal Formulation for the Management of Cancer;Letters in Drug Design & Discovery;2023-10

5. DNA intercalation and topoisomerase inhibition;Medicinal Chemistry of Anticancer Drugs;2023